Investigation of Cosenza Mutation in Patients with Deficiency of Glucose-6-Phosphate Dehydrogenase (G6PD) in North West of Iran

Subject Areas : Journal of Chemical Health Risks

Omolbanin Javadi ¹ , omoalbanin Javadi ² , Habib Onsori ³ , habib onsori ⁴

1 - Genetics Department, Ahar Branch, Islamic Azad University, Ahar, Iran
2 -
3 - Cell and Molecular Biology Department, Marand Branch, Islamic Azad University, Marand, Iran
4 -

Received: 2015-03-08 Accepted : 2018-10-29 Published : 2015-03-08

Keywords: PCR-RFLP, Glucose-6-phosphate dehydrogenase, Cosenza mutation, north- west of Iran, Glucose-6-phosphate dehydrogenase Cosenza mutation PCR-RFLP Iran,

Abstract :

Glucose-6-phosphate dehydrogenase (G6PD) is a greatly polymorphic enzyme encoded by human X-linked gene. G6PD deficit is the most public enzymopathy in human with about 400 million people affected globally. It is the main controlling enzyme in the hexose monophosphate shunt catalase the oxidation of glucose-6-phosphate  to 6-phosphogluconolacton and the creation of reducing equals in the form of NADPH to meet the cellular redox formal and its absence origin hemolytic anemia - favism and newborn jaundice. Mutation in this enzyme cause three major types of unusual phenotype, including Mediterranean, Chatham and Cosenza. In this study, by Rapid Genomic DNA Extraction (RGDE) method, from 90 blood samples of unrelated male and female patients with genetic deficiency of G6PD, DNA was removed and next digestion by Eco81I enzymes, in order to research for Cosenza mutation, they were analyzed by means of PCR-RFLP. Sequencing methods were used. Of 90 patients, one patient had a Cosenza mutation frequency of 1.01%. Eighty-nine patients (98.99%) were not affected by the Cosenza-type mutation. Accordingly, Cosenza mutation is not regarded as the most common mutation in Iranian North-west population.